AMERICAN
NEUROTOLOGY SOCIETY
The 47th Annual Spring Meeting
Manchester Grand Hyatt
San Diego, CA
April 21 - 22, 2012
Deadline for abstract submission: October 15, 2011
THE ABSTRACT SUBMISSION PAGE WILL OPEN JULY 5, 2011.
Abstract Submission Instructions: Please read all instructions
carefully.
Click here to download a pdf version of the instructions. Failure to comply with
the
instructions
could
delay
the
review
of
and/or
disqualify
your
abstract submission. Please contact Kristen Bordignon, ANS Administrator if you
have any questions prior to submitting your abstract.
Email: neurotology65@yahoo.com
Ph: 217-638-0801
Fax: 217-438-6404
The American Neurotology Society accepts on-line submission of abstracts to www.americanneurotologysociety.com
The electronic version is not to contain any extraneous formatting instructions.
Acknowledgment of receipt of an electronic abstract submission will be
sent to
the primary author via email from the ANS Administrator.
The ANS Scientific Program Committee will not consider abstracts that do not
contain the required elements.
Abstracts must be structured according to Otology & Neurotology Guidelines
for Authors
General Format:
A concise abstract of not more than 250 words or less is required
for all original clinical and basic science contributions, including review articles.
The ANS
Scientific Program Committee reviews all abstracts blinded to author; please
do not place any identifying information in the body of the abstract, such as
referral to authorship or institution. Also, if the research in your
paper is supported by a grant, or special financial arrangement, this must be
identified. These should be organized
according to the headings outlined below.
The author(s) must accept sole responsibility for statements in their submitted
abstract.
Choose an appropriate title reflecting the content of the abstract body, as this
title will appear in all publications if chosen for presentation. Do not capitalize
prepositions, a, an, the, etc. Do not include the author’s name(s) in the
abstract title or body.
List all authors in proper sequence (up to six individuals) using first
names,
middle
initials, and last names and exact designations (i.e. MD, PhD, MS, etc.) Specify
the primary author and the presenter of the abstract. Please specify a corresponding
author if different than the Primary author to whom all correspondence about
the abstract will be directed.
The American Neurotology Society requires a completed manuscript be sent
electronically
to the Otology & Neurotology Journal a minimum of three weeks before the
scientific program. Members of the ANS Scientific Program Committee, the CME
Committee and the AOS/ANS Joint Council will review the manuscript for any commercial
bias, conflict of interest, use of commercial names and any other identifying
information that may conflict with the ACCME requirements. The ANS Program Committee
reserves the right to ask you to revise, modify or amend the submitted manuscript/presentation
to ensure compliance with the ACCME requirements. Failure to comply will disqualify
your presentation from the ANS Scientific Program.
For clinical studies:
Objective: Brief, clear statement of the main goals of the investigation.
Study design: Specify the type of study-randomized, prospective double blind;
retrospective case review; etc.
Setting: Primary care vs. Tertiary referral center; ambulatory vs. hospital;
etc.
Patients: Primary eligibility criteria and key demographic features.
Intervention(s): Diagnostic, therapeutic, and/or rehabilitative.
Main outcome measure(s): The most essential criterion that addresses the study’s
central hypothesis.
Results: Include statistical measures where appropriate.
Conclusions: Include only those directly supported by data generated from this
study.
For basic science reports:
Hypothesis: Brief, clear statement of the main goals of the investigation.
Background: Concise orientation for the reader unfamiliar with this line of investigation.
Methods: Succinct summary of techniques and materials employed.
Results: Include statistical measures where appropriate.
Conclusions: Include only those directly supported by data generated from this
study.
Emphasize clinical relevance wherever possible.
For reviews and meta-analysis:
Objective: Brief, clear statement of the goals of the review.
Data sources: Specify database, search methodology, languages covered, and time
frame.
Study selection: Criteria used to select articles for detailed review.
Data extraction: Means of assessing quality, validity, and comparability of extracted
data.
Data synthesis: Specify statistical techniques used for data analysis.
Conclusions: Concise statement of primary inferences with any recommendations.
For All Human and/or Animal Studies: Indicate IRB or IACUC Approval Number
Was outside funding provided for this research/project, if so, you will
be asked
to name the source.
The ANS Scientific Program Committee will not consider abstracts that do not
contain the required elements.
In order to begin the Abstract submission process, the Primary author
must complete
the Conflict of Interest/Disclosure & Attestation form electronically through
the ANS website. Upon successful completion of the COI Disclosure, you will be
directly linked to the Abstract Submission page. As the primary author, it is
your responsibility to see that each author complies with the COI Disclosure
guidelines. To review the content of the Conflict of Interest/Disclosure & Attestation
form prior to your mandatory electronic submission, please click
here for a hard
copy of the document to notify the co-authors of their accountability to disclose.
To simplify the process, after all the author’s have reviewed the Disclosure/Attestation,
the primary author will collect disclosure information from every author named
on the abstract (limited to 6 individuals); list his or her Full name and Designation,
record their specific disclosure, if any, by marking the appropriate checkbox
for each individual.
ONLY AUTHORS NAMED ON THE ELECTRONIC DISCLOSURE WILL BE PUBLISHED IN ANY PROGRAM
MATERIAL.
Conflict
of Interest/Disclosure & Attestation form MUST be submitted electronically.
We will NOT except faxed
forms.
The Abstract submission process cannot be started
until the Conflict
of Interest/Disclosure & Attestation
form has been completed.
Click
here to complete the
mandatory
Conflict of Interest/Disclosure & Attestation
form.
Author Responsibility/Financial Disclosure/Conflict
of Interest & Attestation
Form:
The American Neurotology Society and the AOS/ANS Joint Council, as the ACCME
Accredited CME provider, is dedicated to ensuring that all content reflects the
latest scientific evidence and provides a balanced discussion of topics, advances,
and controversies in this specialty. The ANS and the AOS/ANS Joint Council requires
all authors to comply with the standards set forth by ACCME regarding commercial
bias and/or support. Therefore, all authors (primary and contributing) are responsible
for disclosing any potential conflict of interest prior to consideration of presentation.
Conflict of interest of an individual has two components:
1) A financial relationship with a commercial interest (e.g., pharmaceutical
company or medical device manufacturer)
2) The opportunity to influence content of a CME activity relevant to products
and services of that commercial interest.
• Presentations cannot be focused on new product
development or services but are focused on patient-centric approaches to care.
• The author(s) agree to disclose all non-FDA approved use of FDA approved
drugs or medical devices at the time of abstract submission and prior to the
actual
oral presentation should your abstract be selected for presentation.
In order to comply with the ACCME requirements, the primary author and
contributing authors are required to disclose any conflict of interest or potential
commercial
bias at the time of abstract submission. The primary author accepts responsibility
to electronically submit the conflict of interest/disclosure declarations from
each co-author.
The Abstract Submission page will include the following, please be prepared
to
answer each question/item. It is imperative that both the Abstract title and
Primary author name is an identical match on both the Disclosure form and the
Abstract Submission page. Click
here for an example of an Abstract submission.
TITLE OF ABSTRACT: Capitalize each word in the title, use same
format for the body of the abstract. Do not include the author’s
name(s). (No changes accepted after 10/15/11)
AUTHORS: List all authors in proper sequence (up to 6 maximum) using FIRST NAMES,
MIDDLE INITIALS, and LAST NAMES AND EXACT DESIGNATIONS. (No
changes accepted
after 10/15/11)
NAME, ADDRESS, TELEPHONE, FAX NUMBER, E-MAIL OF PRIMARY AUTHOR:
NAME, ADDRESS, TELEPHONE, FAX NUMBER, E-MAIL OF PRESENTER AT COSM IF OTHER THAN
THE PRIMARY AUTHOR:
IDENTIFICATION OF PROFESSIONAL PRACTICE GAPS, LEARNING OBJECTIVES, & DESIRED
RESULTS
Professional practice gaps are the variations or differences in the practice
patterns of physicians when compared to current evidence, standards of care or
clinical guidelines that are designed to provide optimum patient care. Learning
Objectives are short, clear statements about specific outcomes expected of the
learner. Lastly, list the desired results in terms of changes in physician knowledge,
competence, performance, and/or patient outcome.
Please identify the professional practice gaps, educational needs, learning objectives,
and desired results
Define Professional Practice Gap & Educational Need:
Learning Objective:
Desired Result:
The following competency areas will be addressed - Please click the button in
the
(any/all) competency areas your presentation will address.
• Patient Care that is compassionate, appropriate, and effective for the treatment
of health problems and the promotion of health
• Medical Knowledge about established and evolving biomedical, clinical, and
cognate (e.g. epidemiological and social-behavioral) sciences and the application
of this knowledge to patient care
• Practice-Based Learning and Improvement that involves investigation and evaluation
of their own patient care, appraisal and assimilation of scientific evidence,
and improvements in patient care
• Interpersonal and Communication Skills that result in effective information
exchange and teaming with patients, their families, and other health professionals.
• Professionalism as manifested through a commitment to carrying out professional
responsibilities, adherence to ethical principles, and sensitivity to a diverse
patient population
• Systems-Based Practice as manifested by actions that demonstrate an awareness
of and responsiveness to the larger context and system of health care and the
ability to effectively call on system resources to provide care that is of optimal
value.
Abstract (250 words or less)
IRB or IACUC Approval (if applicable)
Was outside funding provided for this research/project? If so, please
name.
Copyright Transmittal: Abstracts are received with the understanding that they
are not under simultaneous consideration by another publication and that they
are original contributions that have not been previously published. Accepted
abstracts become the permanent property of Otology & Neurotology and may
not be published elsewhere without permission from Otology & Neurotology.
Publication Statement: The material in this abstract, has
not been submitted for publication, published, or presented previously at another
national or international meeting and is not under consideration for presentation
at another national or international meeting including another COSM society.
The penalty for duplicate presentation/publication is prohibition of the author
from presenting at a COSM society meeting for a period of three years.
Please review all instructions carefully. Failure to comply with the instructions
could delay the review of or disqualify your abstract submission. Abstracts submitted
for publication, published, presented previously or considered for presentation
at another national or international meeting may not be submitted. Duplicate
submission to more than one COSM society will disqualify your paper.
Submitting author’s Electronic signature OR Fill in
name:
*Signature indicates author will abide by the above Copyright and Publication
statements:
ANS Administrator
Kristen Bordignon
1980 Warson Rd.
Springfield, IL 62704
Ph: 217-638-0801
Fax: 217-679-1677
Email: neurotology65@yahoo.com
|
